NextPlat (NXPL) Current Leases (2019 - 2026)
NextPlat's (NXPL) quarterly Current Leases came in at $186000.0 in Q2 2026, down 50.79% year-over-year from $378000.0 in Q2 2025, and down 19.48% quarter-over-quarter from $231000.0 in Q1 2026.
Analysis
NextPlat (NXPL) Current Leases (2019 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Current Leases for 8 consecutive years, with $186000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Leases fell 50.79% year-over-year to $186000.0 in Q2 2026; TTM through Jun 2026 was $186000.0, a 50.79% decrease from a year earlier, with the FY2025 full-year figure at $158000.0, down 60.89% from the prior year.
- Current Leases was $186000.0 for Q2 2026 at NextPlat, down from $231000.0 in the prior quarter.
- Over five years, Current Leases peaked at $532000.0 in Q4 2023 and troughed at $11045.0 in Q1 2022.
- A 5-year average of $293199.0 and a median of $293500.0 in 2025 frame the typical range for Current Leases.
- Across the five-year window, Current Leases sank 63.65% in 2022 and surged 1780.79% in 2023, its largest moves.
- Over 5 years, Current Leases stood at $209000.0 in 2022, then jumped by 154.55% to $532000.0 in 2023, then retreated by 24.06% to $404000.0 in 2024, then tumbled by 60.89% to $158000.0 in 2025, then gained by 17.72% to $186000.0 in 2026.
- The last three Current Leases figures came in at $186000.0 (Q2 2026), $231000.0 (Q1 2026), and $158000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 9.04 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | - |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 11.82 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 8.80 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 186,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 186,000.00 |
| Mar 31, 2026 | 231,000.00 |
| Dec 31, 2025 | 158,000.00 |
| Sep 30, 2025 | 356,000.00 |
| Jun 30, 2025 | 378,000.00 |
| Mar 31, 2025 | 392,000.00 |
| Dec 31, 2024 | 404,000.00 |
| Sep 30, 2024 | 381,000.00 |
| Jun 30, 2024 | 380,000.00 |
| Mar 31, 2024 | 532,000.00 |
| Dec 31, 2023 | 532,000.00 |
| Sep 30, 2023 | 366,494.00 |
| Jun 30, 2023 | 204,465.00 |
| Mar 31, 2023 | 207,733.00 |
| Dec 31, 2022 | 209,000.00 |
| Sep 30, 2022 | 145,284.00 |
| Jun 30, 2022 | 203,561.00 |
| Mar 31, 2022 | 11,045.00 |
| Dec 31, 2021 | 19,763.00 |
| Sep 30, 2021 | 27,801.00 |